Evommune
$6.56
3
-$0.17-2.53% 15:05 Today
Statistics
Day High
6.82
Day Low
6.5
52W High
33.2
52W Low
4.94
Volume
79,988
Avg. Volume
792,084
Mkt Cap
238.08M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 10Expected
Q3 2025
Q1 2026
Q2 2026
Next
-8.07
-5.59
-3.12
-0.64
Expected EPS
-0.833511
Actual EPS
N/A
Financials
-529.77%Profit Margin
Unprofitable13MRevenue
-68.87MNet Income
Analyst Ratings
$21.00Average Price Target
The highest estimate is 28.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 57%
Hold 43%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow EVMN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Show More
CEO
Luis C. Pena
Employees
48
Country
United States
ISIN
US30054Y1073
Listings
0 Comments
Share your thoughts
FAQs
What is Evommune stock price today?▼
The current price of EVMN is $6.56 USD — it has decreased by -2.53% in the past 24 hours. Watch Evommune stock price performance more closely on the chart.
What is Evommune stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Evommune stocks are traded under the ticker EVMN.
What is Evommune market cap?▼
Today Evommune has the market capitalization of 238.08M
When is the next Evommune earnings date?▼
Evommune is going to release the next earnings report on December 10, 2026.
What were Evommune earnings last quarter?▼
EVMN earnings for the last quarter are -0.89 USD per share, whereas the estimation was -0.66 USD resulting in a -33.94% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Evommune revenue for the last year?▼
Evommune revenue for the last year amounts to 13M USD.
What is Evommune net income for the last year?▼
EVMN net income for the last year is -68.87M USD.
How many employees does Evommune have?▼
As of November 2, 2026, the company has 48 employees.
In which sector is Evommune located?▼
Evommune operates in the Health & Wellness sector.
When did Evommune complete a stock split?▼
Evommune has not had any recent stock splits.
Where is Evommune headquartered?▼
Evommune is headquartered in PALO ALTO, United States.